Evaluation of an Adapted Physical Activity Program in Patients With Unresectable Pancreatic Cancer

  • days left to enroll
  • participants needed
  • sponsor
    GERCOR - Multidisciplinary Oncology Cooperative Group
Updated on 23 January 2021
Pascal HAMMEL, PhD
Primary Contact
CHU Morvan (0.4 mi away) Contact
+27 other location
measurable disease
pancreatic adenocarcinoma
unresectable pancreatic cancer


Adapted Physical Activity (APA) program may provide an opportunity to improve symptoms for patients with unresectable pancreatic cancer.

Thereby, it is proposed to conduct an open trial to assess effects of the APA program in such population


The benefit of Adapted Physical Activity (APA) has been demonstrated after cancer diagnosis in term of symptomatic improvement: reducing fatigue, pain and improving the quality of life, psychological and emotional state, and adherence to treatment.

The aim of the study is to assess the effects of an APA program in pancreatic cancer population treated by usual chemotherapy.

200 randomized patients are required.

The program is organized in 16 weeks. During the trial, assessments include: aerobic exercises, muscular strength, six-minute walk test, body composition (bioimpedance, L3 CT-scan), level of physical activity - International Physical Activity Questionnaire - (IPAQ questionnaire), fatigue - Multidimensional Fatigue Inventory - (MFI-20 questionnaire), quality of life - EORTC Quality of Life questionnaire C-30 - (EORTC QLQ-30 questionnaire), depression symptom - Hospital Anxiety and depression scale - (HADS questionnaire), pain (Brief Pain Inventory Short form), and nutritional evaluation (BMI, ingests EVA).

Furthermore, relationships between insulin resistance, insulin secretion, Insulin like Growth Factor 1 (IGF-1) and pancreatic carcinogenesis exist. APA may improve the quality of life in decreasing insulin-resistance, insulin secretion and IGF-1.

Condition Metastatic Pancreatic Cancer, Unresectable Locally Advanced Cancer
Treatment without APA program, APA program
Clinical Study IdentifierNCT02184663
SponsorGERCOR - Multidisciplinary Oncology Cooperative Group
Last Modified on23 January 2021


Yes No Not Sure

Inclusion Criteria

Histologically proven non resectable pancreatic adenocarcinoma
Indication of palliative chemotherapy
Life expectancy 3 months
Eastern Cooperative oncology group (ECOG) - Performance status 2
Age 18 years old
At least one measurable lesion as assessed by CT-scan or MRI (Magnetic resonance Imaging)
Identified Accompanying partner Adapted Physical Activity (AAPA)
Signed and dated informed consent
Registration in a National Health Care System (CMU included for France)

Exclusion Criteria

Previous Cerebrovascular accident or myocardial infarction <6months
Uncontrolled hypertension
Severe cardiovascular or respiratory disease
Severe cognitive or psychiatric disorder
Severe motor and/or sensory neuropathy
Rheumatologic or orthopedic problem or bone lesions with a fracture risk
Others comorbidities contra-indicated physical exercises
Patient protected by the law - Guardianship and trusteeship
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Preferred Language
Other Language
Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note